Latest & greatest articles for type 2 diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on type 2 diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on type 2 diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for type 2 diabetes

1. A systematic review of illness perception interventions in type 2 diabetes: Effects on glycaemic control and illness perceptions

A systematic review of illness perception interventions in type 2 diabetes: Effects on glycaemic control and illness perceptions A systematic review of illness perception interventions in type 2 diabetes: Effects on glycaemic control and illness perceptions - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Review Diabet Med Actions . 2021 Mar;38(3):e14495. doi: 10.1111/dme.14495. Epub 2020 Dec 30. A systematic review of illness perception interventions in type 2 diabetes: Effects on glycaemic control and illness perceptions , , , , Affiliations Expand Affiliations 1 Department of Psychological Medicine, University of Auckland, Auckland

2021 EvidenceUpdates

2. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update — The User’s Guide

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update — The User’s Guide My Site - Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update — The User’s Guide Diabetes Canada | Clinical Practice Guidelines The Canadian Diabetes Association has become Diabetes Canada* Search: Guidelines Key Messages For Health-Care Providers For People with Diabetes Other Languages Links Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update (...) recommendations or the rationale behind their grading. Additional clinical practice tools and resources are being developed to support persons with diabetes and to help prescribers apply the updated guidelines. Questions General Are Diabetes Canada’s guidelines too glucocentric? The update on pharmacotherapy for type 2 diabetes is only one part of our clinical practice guidelines (CPG) which aim to take a holistic, patient-centred approach. Reducing microvascular and cardiovascular (CV) complications

2021 Diabetes Canada

3. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update

glycemic management of type 2 diabetes in adults: 2020 update - the user’s guide. Can J Diabetes 2020; 44:589e93. Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med 2016;164:740e51. Mearns ES, Sobieraj DM, White CM, et al. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: A network meta (...) -analysis. PLoS ONE 2015;10: e0125879. Mishriky BM, Cummings DM, Tanenberg RJ. The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2015;109:378e88. Foroutan N, Muratov S, Levine M. Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis

2021 Diabetes Canada

4. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

options Display options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2021 Apr;44(4):901-907. doi: 10.2337/dc20-2586. Epub 2021 Jan 28. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes , , , , , , , , , Affiliations Expand Affiliations 1 Steno Diabetes Center Copenhagen, Gentofte, Denmark dorte.vistisen@regionh.dk. 2 Steno Diabetes Center Copenhagen, Gentofte, Denmark. 3 Steno Diabetes Center Aarhus, Aarhus, Denmark. 4 University of Edinburgh (...) A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Show account info Close Account Logged in as: username Search: Search Save

2021 EvidenceUpdates

5. Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes Full Text available with Trip Pro

Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Show account info Close Account (...) Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Circulation Actions . 2021 Feb 9;143(6):540-552. doi: 10.1161/CIRCULATIONAHA.120.051898. Epub 2020 Nov 16. Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes , , , , , , , , , , , Affiliations Expand Affiliations 1 National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Greece

2021 EvidenceUpdates

6. Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial Full Text available with Trip Pro

Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Am J Kidney Dis Actions . 2020 Oct 29;S0272-6386(20)31072-6. doi: 10.1053/j.ajkd.2020.09.009. Online ahead of print. Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial , , , , , , Affiliations Expand Affiliations 1

2021 EvidenceUpdates

7. Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study Full Text available with Trip Pro

Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Show account info Close Account Logged (...) Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2021 Jan 27. doi: 10.1111/dom.14330. Online ahead of print. Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study , , , , , , Affiliations Expand Affiliations 1 School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea. 2 Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Republic of Korea. 3

2021 EvidenceUpdates

8. Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other (...) for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Res Clin Pract Actions . 2021 Feb;172:108656. doi: 10.1016/j.diabres.2021.108656. Epub 2021 Jan 9. Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta

2021 EvidenceUpdates

9. Effects of aerobic training with and without progression on blood pressure in patients with type 2 diabetes: A systematic review with meta-analyses and meta-regressions

Effects of aerobic training with and without progression on blood pressure in patients with type 2 diabetes: A systematic review with meta-analyses and meta-regressions Effects of aerobic training with and without progression on blood pressure in patients with type 2 diabetes: A systematic review with meta-analyses and meta-regressions - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several (...) a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Meta-Analysis Diabetes Res Clin Pract Actions . 2021 Jan;171:108581. doi: 10.1016/j.diabres.2020.108581. Epub 2020 Dec 8. Effects of aerobic training with and without progression on blood pressure in patients with type 2 diabetes: A systematic review

2021 EvidenceUpdates

10. Rapid Changes in Serum Testosterone in Men with Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin

Rapid Changes in Serum Testosterone in Men with Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2021 Apr;44(4):1059-1061. doi: 10.2337/dc20-1558. Epub 2021 Feb 3. Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin , , , , , , , , Affiliations Expand Affiliations 1 Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China. 2

2021 EvidenceUpdates

11. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis

Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Review Diabetes Care Actions . 2020 Jul;43(7):1650-1658. doi: 10.2337/dc19-1708. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis , , , , , , , , , , Affiliations Expand Affiliations 1 West China Hospital, Sichuan University, Chengdu

2021 EvidenceUpdates

12. Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta-analysis

Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta-analysis Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several (...) a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabet Med Actions . 2021 Apr;38(4):e14525. doi: 10.1111/dme.14525. Epub 2021 Feb 1. Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta-analysis

2021 EvidenceUpdates

13. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression Full Text available with Trip Pro

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression , , , , Affiliations Expand Affiliations 1 HUMANITAS Gradenigo, Turin, Italy. 2 Department of Cardiology, Azienda Ospedaliero Universitaria, Sassari, Italy. 3 Laboratory of Diabetes and Metabolic disorders, Department of Medical Sciences, University of Turin, Turin, Italy. PMID: 33373368 PMCID: DOI: Free PMC article Item in Clipboard Meta-Analysis Assessing the risk of ketoacidosis due to sodium-glucose

2021 EvidenceUpdates

14. Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes Full Text available with Trip Pro

: 31377056 Clinical Trial. References REFERENCES Nadeau KJ, Regensteiner JG, Bauer TA, et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab. 2010;95(2):513-521. . Bjornstad P, Maahs DM, Duca LM, et al. Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study. J Diabetes Complications. 2016;30 (...) navigation Diabetes Obes Metab Actions . 2020 Nov 25. doi: 10.1111/dom.14266. Online ahead of print. Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes , , , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. 2 Barbara Davis Center

2021 EvidenceUpdates

15. Efficacy and safety of adding sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline BMI >/=27 kg/m(2) Full Text available with Trip Pro

Efficacy and safety of adding sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline BMI >/=27 kg/m(2) Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m 2 - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m 2 , , , , , , , Affiliations Expand Affiliations 1 Diabetes-Zentrum für Kinder und Judendliche, Kinder- und Jugendkrankenhaus AUF DER BULT, Hannover, Germany. 2 Department of Medicine, University of California San Diego, Veterans Affairs Medical Center, San Diego, California. 3 Taking Control of Your Diabetes, Solana

2021 EvidenceUpdates

16. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial

With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial Helga Blauw et al. Diabetes Care . 2021 . Show details Display options Display options Format Diabetes Care Actions . 2021 Jan 4;dc202106. doi: 10.2337/dc20-2106. Online ahead of print. Authors , , , , Affiliations 1 Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands h.blauw@amsterdamumc.nl. 2 Inreda Diabetic, Goor, the Netherlands. 3 Department (...) of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands. 4 Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. PMID: 33397767 DOI: Item in Clipboard Full text links Cite Display options Display options Format Abstract Objective: To demonstrate the performance and safety of a bihormonal (insulin and glucagon) artificial pancreas (AP) in adults with type 1 diabetes. Research design and methods: In this outpatient, randomized, crossover trial, 2-week

2021 EvidenceUpdates

17. Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF Full Text available with Trip Pro

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2021 Feb;44(2):586-594. doi: 10.2337/dc20-1675. Epub 2020 Dec 18. Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection

2021 EvidenceUpdates

18. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2021 Feb;44(2):473-478. doi: 10.2337/dc20-1729. Epub 2020 Dec 21. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Jaeb Center for Health Research, Tampa, FL. 2 Barbara Davis Center (...) of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes Lauren G Kanapka et al. Diabetes Care . 2021 Feb . Show details Display options Display options Format Diabetes Care Actions . 2021 Feb;44(2):473-478. doi: 10.2337/dc20-1729. Epub 2020 Dec 21. Authors , , , , , , , , , , , , , , , , , , , , Affiliations 1 Jaeb Center for Health Research, Tampa, FL. 2 Barbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, CO. 3 Center for Diabetes Technology

2021 EvidenceUpdates

19. Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials

Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials - PubMed This site needs JavaScript to work properly. Please enable it to take (...) . Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials , , Affiliations Expand Affiliations 1 School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Victoria, Australia s.mason@deakin.edu.au. 2 Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia. PMID

2021 EvidenceUpdates

20. A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study Full Text available with Trip Pro

A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) : Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2021 Mar;23(3):811-821. doi: 10.1111/dom.14288. Epub 2021 Jan 8. A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study

2021 EvidenceUpdates